SCHEMBL3940833

SCHEMBL3940833

C1CCC(Cc2nnn[nH]2)CC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.38
HTR3A P46098 1/20 0.38
ADORA2A P29274 3/20 0.34
GSK3B P49841 2/20 0.33
JAK2 O60674 1/20 0.33
ROCK2 O75116 1/20 0.33
PDE9A O76083 3/20 0.33
ADORA2B P29275 2/20 0.33
DAO P14920 2/20 0.33
AAK1 Q2M2I8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.31
ADORA1 P30542 1/20 0.31
PDE5A O76074 1/20 0.30
PDE1C Q14123 1/20 0.30
CCNB2 O95067 1/20 0.30
CDK1 P06493 1/20 0.30
CCNB1 P14635 1/20 0.30
GSK3A P49840 1/20 0.30
CCNB3 Q8WWL7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6612499 0.90
SCHEMBL7053027 0.83 HRH3 (0.30) HRH3
SCHEMBL13406456 0.82 GBA1 (0.40) HRH4HRH3
SCHEMBL6476895 0.82
SCHEMBL19655652 0.81
SCHEMBL19599020 0.81 PLG (0.31)
SCHEMBL17501499 0.81 PLG (0.31)
SCHEMBL9220394 0.77
SCHEMBL21788711 0.77 HDAC6 (0.37) HRH4HRH3
SCHEMBL4761272 0.77 HDAC6 (0.37) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307739-A1 NRF2 REGULATORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-04-18 EP disclosed
WO-2016202253-A1 NRF2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-12-22 WO disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed